News
5don MSN
If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
Recursion Pharmaceuticals (RXRX 0.02%), a biotech company focused on artificial intelligence (AI), went public in April 2021. This was before ChatGPT, before AI became the hottest ...
16don MSN
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...
CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common stock. Chief R&D and commercial officer Najit Khan was also a seller; she ...
Recursive Descent Syntax Recogniser This project implements a recursive descent parser and syntax analyser in Java. Developed for the SCC312 Compilers module, it reads and checks the syntactic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback